Vanberra Signal

Bardy Diagnostics

Curated by Signal

Develops and markets the Carnation Ambulatory Monitor

Overview

Bardy Diagnostics is engaged in the development and marketing of the Carnation Ambulatory Monitor ("CAM"), the smallest and lightest P-wave centric ambulatory cardiac monitor and arrhythmia detection device int he world. It can be worn comfortably for up to 7 days. The device focus on the P-wave as a new tool for cardiologists to diagnose arrhythmias with high precision.

Key facts

Founded
2013

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of fetal heart rate monitoring device

    Life Sciences TechnologyAtlanta, United States
  • Glucose monitoring device

    Life Sciences TechnologyWestlake Village, United States
  • Provider of AI-based platform for DNA sequencing

    Life Sciences TechnologyNew York City, United States

About Bardy Diagnostics

What does Bardy Diagnostics do?

Bardy Diagnostics is engaged in the development and marketing of the Carnation Ambulatory Monitor ("CAM"), the smallest and lightest P-wave centric ambulatory cardiac monitor and arrhythmia detection device int he world.

Where is Bardy Diagnostics headquartered?

Bardy Diagnostics is headquartered in Charlotte, United States.

When was Bardy Diagnostics founded?

Bardy Diagnostics was founded in 2013.

Which sector is Bardy Diagnostics in?

Bardy Diagnostics operates in Life Sciences Technology.

Who are Bardy Diagnostics's competitors?

Companies similar to Bardy Diagnostics include Libi Medical, PharmaTech Solutions, and New Amsterdam Genomics.